Dual Diagnosis
26
2
3
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
12 trials with published results (46%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
7.7%
2 terminated out of 26 trials
90.0%
+3.5% vs benchmark
23%
6 trials in Phase 3/4
67%
12 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (26)
CRP and S&A for Inpatient Veterans
Psychosocial Factors in Dual Diagnosis in a General Hospital
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
VR Based Therapy to Treat Anxiety in Dual Diagnosis
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Clozapine for Cannabis Use in Schizophrenia
Benefits Management for People With Psychiatric Disabilities
Abstinence-Linked Money Management Multisite
Dual Diagnosis Self-Help Referral
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: Effects of Clozapine
Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1